Literature DB >> 9126354

Identification of a domain of lecithin-cholesterol acyltransferase that is involved in interfacial recognition.

S Adimoolam1, A Jonas.   

Abstract

Lecithin-cholesterol acyltransferase (LCAT) is an interfacial enzyme that acts on lipid substrates on the surface of high density lipoproteins (HDL). Based on observations with other interfacial lipases, we propose that LCAT contains a surface region of 25 amino acids linked by a disulfide bond (C50-C74) that is involved in the binding of LCAT to lipoproteins. Using LCAT cDNA, we have deleted most of this region (delta 53-71) and expressed the mutant enzyme (LCAT delta 53-71) in COS-1 cells. The deletion mutant is expressed and secreted at levels similar to wildtype LCAT, suggesting that the deleted region is located on the surface of the enzyme and is not required for folding. The enzymatic activity of the mutant was tested using two interfacial substrates, reconstituted HDL (rHDL) and low density lipoprotein (LDL), as well as a water soluble substrate, p-nitrophenyl butyrate (PNPB). There was no reaction with rHDL and LDL, but 30% of the activity with PNPB was retained. This suggests that the deleted region plays a role in interfacial binding, while the active site core is not disrupted. We thus conclude that this region (C50-C74) forms part of the interfacial binding domain of LCAT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126354     DOI: 10.1006/bbrc.1997.6375

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

2.  Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity.

Authors:  Alexander D Dergunov
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

3.  Kinetic analysis of lecithin:cholesterol acyltransferase activity toward discoidal HDL.

Authors:  Alexander D Dergunov
Journal:  Lipids       Date:  2011-09-24       Impact factor: 1.880

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.

Authors:  Kewei Wang; Papasani V Subbaiah
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  The high-resolution crystal structure of human LCAT.

Authors:  Derek E Piper; William G Romanow; Ruwanthi N Gunawardane; Preston Fordstrom; Stephanie Masterman; Oscar Pan; Stephen T Thibault; Richard Zhang; David Meininger; Margrit Schwarz; Zhulun Wang; Chadwick King; Mingyue Zhou; Nigel P C Walker
Journal:  J Lipid Res       Date:  2015-07-20       Impact factor: 5.922

7.  Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.

Authors:  Lita A Freeman; Stephen J Demosky; Monika Konaklieva; Rostislav Kuskovsky; Angel Aponte; Alice F Ossoli; Scott M Gordon; Ross F Koby; Kelly A Manthei; Min Shen; Boris L Vaisman; Robert D Shamburek; Ajit Jadhav; Laura Calabresi; Marjan Gucek; John J G Tesmer; Rodney L Levine; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2017-06-02       Impact factor: 4.030

8.  Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.

Authors:  Marco G Casteleijn; Petteri Parkkila; Tapani Viitala; Artturi Koivuniemi
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

9.  Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile.

Authors:  Akseli Niemelä; Artturi Koivuniemi
Journal:  PLoS Comput Biol       Date:  2021-03-15       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.